HDFC Mutual Fund Increases Stake in Global Health with ₹130 Crore Deal
HDFC Mutual Fund has further strengthened its position in Global Health, the parent company of the renowned Medanta hospital chain, through a significant open market transaction. This latest acquisition underscores the institutional investor's growing confidence in the healthcare major's long-term growth trajectory.
Strategic Acquisition via Open Market Transaction
In a major block deal recorded on the BSE, HDFC Mutual Fund acquired an additional 10 lakh shares of Global Health. The transaction was executed at an average price of ₹1,300 per share, amounting to a total investment of ₹130 crore. This purchase represents a 0.37 per cent stake in the healthcare company.
The shares were offloaded by Sunil Sachdeva, a co-founder of Medanta Hospitals. This move follows a similar transaction last month, where HDFC Mutual Fund purchased 10 lakh shares from Sachdeva for over ₹122 crore. As of the end of the March quarter, Sachdeva held a 10.79 per cent stake in the company, consisting of 2.90 crore equity shares.
Robust Financial Performance Drives Investor Interest
The increased institutional interest comes on the heels of impressive financial results reported by Global Health. For the fourth quarter ended March 31, 2026, the company demonstrated significant bottom-line growth, reporting a 39.7 per cent increase in Profit After Tax (PAT). The PAT rose to ₹141.7 crore, up from ₹101.4 crore in the same quarter of the previous fiscal year.
Revenue from operations also showed a strong upward trend, climbing to ₹1,159 crore in the most recent quarter, compared to ₹931.3 crore in the year-ago period. This substantial growth in both top-line revenue and net profitability highlights the company's operational efficiency and its successful expansion within the competitive healthcare sector.
Market Reaction and Sector Outlook
Despite the significant news regarding the block deal, the broader market saw slight volatility for the stock. Shares of Global Health closed at ₹1,311.35 on the BSE, marking a marginal slip of 0.41 per cent.
The continuous accumulation of shares by a heavyweight like HDFC Mutual Fund suggests that institutional players view the Medanta brand's ability to scale and maintain high-margin operations as a key driver for future valuation. As the healthcare sector in India continues to undergo consolidation and expansion, Global Health's strong quarterly earnings position it as a formidable player for long-term investors.
Key Takeaways
- Significant Investment: HDFC Mutual Fund acquired 10 lakh shares of Global Health for ₹130 crore at an average price of ₹1,300 per share.
- Strong Financial Growth: Global Health reported a nearly 40% jump in PAT to ₹141.7 crore and a significant increase in quarterly revenue to ₹1,159 crore.
- Co-founder Exit: The shares were purchased from Medanta co-founder Sunil Sachdeva, marking a consecutive month of share sales by him to HDFC Mutual Fund.